Irregular-Shaped Hematoma Predicts Postoperative Rehemorrhage After Stereotactic Minimally Invasive Surgery for Intracerebral Hemorrhage

被引:5
作者
Wang, Likun [1 ]
Luo, Sheng [1 ]
Ren, Siying [1 ]
Yu, Hui [1 ]
Shen, Guiquan [1 ]
Wu, Guofeng [1 ]
Yang, Qingwu [2 ]
机构
[1] Guizhou Med Univ, Affiliated Hosp, Guiyang, Peoples R China
[2] Army Mil Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
intracerebral hemorrhage; stereotactic minimally invasive surgery; regular-shaped hematoma; irregular-shaped hematoma; postoperative rehaemorrhage; EVACUATION; MANAGEMENT; GUIDELINES; DENSITY; PHASE;
D O I
10.3389/fneur.2022.727702
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and PurposeMinimally invasive surgery (MIS) is performed to treat patients with intracerebral hemorrhage (ICH) with favorable results. However, postoperative rehemorrhage is a significant risk. The present study retrospectively analyzed the association of irregular-shaped hematoma with postoperative rehemorrhage following stereotactic MIS (sMIS). MethodsWe enrolled 548 patients with spontaneous ICH who underwent sMIS. Based on the hematoma shape, the patients were assigned to the regular-shaped hematoma group (RSH group; 300 patients) or irregular-shaped hematoma group (ISH group; 248 patients). Logistic regression analysis was performed to identify the predictors of postoperative rehemorrhage after sMIS for ICH evacuation. The functional outcome was assessed using the modified ranking scale (mRS) score at discharge. A receiver operating characteristic (ROC) curve was used to confirm the results. ResultsAmong 548 patients with ICH who underwent sMIS, 116 developed postoperative rehemorrhage. Postoperative rehemorrhage occurred in 30.65% of patients with ISH and 13.30% with RSH (P < 0.01), with a significant difference between the ISH and RSH groups. Among 116 patients with postoperative rehemorrhage, 76 (65.52%) showed ISH on CT scan. In 432 patients without postoperative rehemorrhage, only 39.81% displayed ISH. The logistic regression analysis demonstrated that ISH could independently predict postoperative rehemorrhage. The sensitivity, specificity, positive predictive value, and negative predicative value were 0.655, 0.398, 0.655, and 0.602, respectively. The ROC analysis confirmed the value of ISH in predicting postoperative rehemorrhage with an area under the curve of 0.629. ConclusionsIrregular-shaped hematoma was an independent predictor of postoperative rehemorrhage after sMIS.
引用
收藏
页数:9
相关论文
共 34 条
  • [1] Trends in Surgical Management and Mortality of Intracerebral Hemorrhage in the United States Before and After the STICH Trial
    Adeoye, Opeolu
    Ringer, Andrew
    Hornung, Richard
    Khatri, Pooja
    Zuccarello, Mario
    Kleindorfer, Dawn
    [J]. NEUROCRITICAL CARE, 2010, 13 (01) : 82 - 86
  • [2] Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure
    Awad, Issam A.
    Polster, Sean P.
    Carrion-Penagos, Julian
    Thompson, Richard E.
    Cao, Ying
    Stadnik, Agnieszka
    Money, Patricia Lynn
    Fam, Maged D.
    Koskimaeki, Janne
    Girard, Romuald
    Lane, Karen
    McBee, Nichol
    Ziai, Wendy
    Hao, Yi
    Dodd, Robert
    Carlson, Andrew P.
    Camarata, Paul J.
    Caron, Jean-Louis
    Harrigan, Mark R.
    Gregson, Barbara A.
    Mendelow, A. David
    Zuccarello, Mario
    Hanley, Daniel F.
    Abdul-Rahim, Azmil
    Abou-Hamden, Amal
    Abraham, Michael
    Ahmed, Azam
    Alba, Carlos Alarcon
    Aldrich, E. Francois
    Ali, Hasan
    Altschul, David
    Amin-Hanjani, Sepideh
    Anderson, Craig S.
    Anderson, Doug
    Ansari, Safdar
    Antezana, David
    Ardelt, Agnieszka
    Arikan, Fuat
    Avadhani, Radhika
    Baguena, Marcelino
    Baker, Alexandra
    Barrer, Steven J.
    Barzo, Pal
    Becker, Kyra J.
    Bergman, Thomas
    Betz, Joshua F.
    Bistran-Hall, Amanda J.
    Bostrom, Azize
    Braun, Jamie
    Brindley, Peter
    [J]. NEUROSURGERY, 2019, 84 (06) : 1157 - 1167
  • [3] Density and Shape as CT Predictors of Intracerebral Hemorrhage Growth
    Barras, Christen D.
    Tress, Brian M.
    Christensen, Soren
    MacGregor, Lachlan
    Collins, Marnie
    Desmond, Patricia M.
    Skolnick, Brett E.
    Mayer, Stephan A.
    Broderick, Joseph P.
    Diringer, Michael N.
    Steiner, Thorsten
    Davis, Stephen M.
    [J]. STROKE, 2009, 40 (04) : 1325 - 1331
  • [4] Modern Approaches to Evacuating Intracerebral Hemorrhage
    Bhatia, Kunal
    Hepburn, Madihah
    Ziu, Endrit
    Siddiq, Farhan
    Qureshi, Adnan I.
    [J]. CURRENT CARDIOLOGY REPORTS, 2018, 20 (12)
  • [5] Early hemorrhage growth in patients with intracerebral hemorrhage
    Brott, T
    Broderick, J
    Kothari, R
    Barsan, W
    Tomsick, T
    Sauerbeck, L
    Spilker, J
    Duldner, J
    Khoury, J
    [J]. STROKE, 1997, 28 (01) : 1 - 5
  • [6] Predictors of hematoma expansion predictors after intracerebral hemorrhage
    Chen, Sheng
    Zhao, Binjie
    Wang, Wei
    Shi, Ligen
    Reis, Cesar
    Zhang, Jianmin
    [J]. ONCOTARGET, 2017, 8 (51) : 89348 - 89363
  • [7] The ABCs of Accurate Volumetric Measurement of Cerebral Hematoma
    Divani, Afshin A.
    Majidi, Shahram
    Luo, Xianghua
    Souslian, Fotis G.
    Zhang, Jie
    Abosch, Aviva
    Tummala, Ramachandra P.
    [J]. STROKE, 2011, 42 (06) : 1569 - 1574
  • [8] Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial
    Britz, Gavin W.
    [J]. NEUROSURGERY, 2017, 81 (05) : 866 - 866
  • [9] Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial
    Hanley, Daniel F.
    Thompson, Richard E.
    Rosenblum, Michael
    Yenokyan, Gayane
    Lane, Karen
    McBee, Nichol
    Mayo, Steven W.
    Bistran-Hall, Amanda J.
    Gandhi, Dheeraj
    Mould, W. Andrew
    Ullman, Natalie
    Ali, Hasan
    Carhuapoma, J. Ricardo
    Kase, Carlos S.
    Lees, Kennedy R.
    Dawson, Jesse
    Wilson, Alastair
    Betz, Joshua F.
    Sugar, Elizabeth A.
    Hao, Yi
    Avadhani, Radhika
    Caron, Jean-Louis
    Harrigan, Mark R.
    Carlson, Andrew P.
    Bulters, Diederik
    LeDoux, David
    Huang, Judy
    Cobb, Cully
    Gupta, Gaurav
    Kitagawa, Ryan
    Chicoine, Michael R.
    Patel, Hiren
    Dodd, Robert
    Camarata, Paul J.
    Wolfe, Stacey
    Stadnik, Agnieszka
    Money, P. Lynn
    Mitchell, Patrick
    Sarabia, Rosario
    Harnof, Sagi
    Barzo, Pal
    Unterberg, Andreas
    Teitelbaum, Jeanne S.
    Wang, Weimin
    Anderson, Craig S.
    Mendelow, A. David
    Gregson, Barbara
    Janis, Scott
    Vespa, Paul
    Ziai, Wendy
    [J]. LANCET, 2019, 393 (10175) : 1021 - 1032
  • [10] Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial
    Hanley, Daniel F.
    Thompson, Richard E.
    Muschelli, John
    Rosenblum, Michael
    McBee, Nichol
    Lane, Karen
    Bistran-Hall, Amanda J.
    Mayo, Steven W.
    Keyl, Penelope
    Gandhi, Dheeraj
    Morgan, Tim C.
    Ullman, Natalie
    Mould, W. Andrew
    Carhuapoma, J. Ricardo
    Kase, Carlos
    Ziai, Wendy
    Thompson, Carol B.
    Yenokyan, Gayane
    Huang, Emily
    Broaddus, William C.
    Graham, R. Scott
    Aldrich, E. Francois
    Dodd, Robert
    Wijman, Cristanne
    Caron, Jean-Louis
    Huang, Judy
    Camarata, Paul
    Mendelow, A. David
    Gregson, Barbara
    Janis, Scott
    Vespa, Paul
    Martin, Neil
    Awad, Issam
    Zuccarello, Mario
    [J]. LANCET NEUROLOGY, 2016, 15 (12) : 1226 - 1235